Ballast Advisors LLC Amgen Inc Transaction History

Ballast Advisors LLC

$314 Million
Q2 2024

A detailed history of Ballast Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Ballast Advisors LLC holds 1,460 shares of AMGN stock, worth $461,360. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,460

Previous 1,594 8.41%

Holding current value

$461,360

Previous $453,000 0.66%

% of portfolio

0.15%

Previous 0.15%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$262.75 - $319.31 $35,208 - $42,787	-134 Reduced 8.41%	1,460 $456,000
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $15,056 - $18,175	-56 Reduced 3.39%	1,594 $453,000
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $27,359 - $30,865	-107 Reduced 6.09%	1,650 $475,000
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $11,151 - $13,844	-51 Reduced 2.82%	1,757 $472,000
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $4,928 - $5,827	-23 Reduced 1.26%	1,808 $401,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $2,032 - $2,476	-9 Reduced 0.49%	1,831 $442,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $1,832 - $2,328	-8 Reduced 0.43%	1,840 $0
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $9,651 - $10,885	-43 Reduced 2.27%	1,848 $417,000
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $692 - $770	3 Added 0.16%	1,891 $460,000
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $36,618 - $40,509	167 Added 9.7%	1,888 $457,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $1,392 - $1,593	7 Added 0.41%	1,721 $387,000
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $28,345 - $33,754	-131 Reduced 7.1%	1,714 $394,000
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $5,538 - $6,796	-28 Reduced 1.49%	1,845 $435,000
Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $728 - $966	-4 Reduced 0.21%	1,873 $380,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $355,147 - $456,486	1,877 New	1,877 $452,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballast Advisors LLC with notifications on news.

Account

Ballast Advisors LLC Amgen Inc Transaction History